Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (3003)
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,699
Price
$28.82
Total Value
$193.07K
Shares Held After
382,984
% of Holdings
1.7%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
1,694
Price
$2.06
Total Value
$3.49K
Shares Held After
2,858,657
% of Holdings
0.1%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
18,182
Price
$1.33
Total Value
$24.18K
Shares Held After
935,021
% of Holdings
1.9%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research&Investments
Shares
4,126
Price
$57.10
Total Value
$235.59K
Shares Held After
0
% of Holdings
100.0%
ImmunityBio, Inc. (IBRX)
Cohen Cheryl — Director
Shares
81,056
Price
$10.50
Total Value
$851.09K
Shares Held After
100,309
% of Holdings
44.7%
Pelthos Therapeutics Inc. (PTHS)
Pauls Matthew — Director
Shares
786
Price
$21.00
Total Value
$16.51K
Shares Held After
13,578
% of Holdings
5.5%
Pelthos Therapeutics Inc. (PTHS)
Friedberg Ezra M — Director
Shares
558
Price
$20.72
Total Value
$11.56K
Shares Held After
80,484
% of Holdings
0.7%
Pelthos Therapeutics Inc. (PTHS)
Greenleaf Peter — Director
Shares
797
Price
$21.17
Total Value
$16.87K
Shares Held After
23,087
% of Holdings
3.3%
BICYCLE THERAPEUTICS PLC (BCYC)
Swanton Robert Charles — Director
Shares
3,431
Price
$3.47
Total Value
$11.91K
Shares Held After
15,782
% of Holdings
17.9%
BICYCLE THERAPEUTICS PLC (BCYC)
Lee Kevin — Director
Shares
6,167
Price
$3.47
Total Value
$21.40K
Shares Held After
597,504
% of Holdings
1.0%
BICYCLE THERAPEUTICS PLC (BCYC)
Skynner Michael — CHIEF SCIENTIFIC OFFICER
Shares
1,942
Price
$3.47
Total Value
$6.74K
Shares Held After
155,229
% of Holdings
1.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Perry Jennifer Scott — Chief Operating Officer
Shares
1,094
Price
$3.47
Total Value
$3.80K
Shares Held After
89,958
% of Holdings
1.2%
BICYCLE THERAPEUTICS PLC (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD&SUPPLY CHAIN OFF
Shares
1,572
Price
$3.47
Total Value
$5.45K
Shares Held After
92,803
% of Holdings
1.7%
OCULAR THERAPEUTIX, INC (OCUL)
Heier Jeffrey S. — Chief Scientific Officer
Shares
10,869
Price
$7.05
Total Value
$76.63K
Shares Held After
307,457
% of Holdings
3.4%
OCULAR THERAPEUTIX, INC (OCUL)
Kaiser Peter — Chief Development Officer
Shares
9,990
Price
$7.05
Total Value
$70.43K
Shares Held After
254,388
% of Holdings
3.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
17
Price
$307.74
Total Value
$5.23K
Shares Held After
31,854
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
235
Price
$307.19
Total Value
$72.19K
Shares Held After
31,871
% of Holdings
0.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
404
Price
$306.18
Total Value
$123.70K
Shares Held After
32,106
% of Holdings
1.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,535
Price
$304.52
Total Value
$467.43K
Shares Held After
32,510
% of Holdings
4.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
1,976
Price
$303.54
Total Value
$599.80K
Shares Held After
34,045
% of Holdings
5.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO&Secretary
Shares
833
Price
$302.51
Total Value
$251.99K
Shares Held After
36,021
% of Holdings
2.3%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,500
Price
$16.00
Total Value
$40.00K
Shares Held After
27,000
% of Holdings
9.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
SUPRAN BRYAN — EVP, CLO and Secretary
Shares
1,758
Price
$226.88
Total Value
$398.86K
Shares Held After
12,807
% of Holdings
12.1%
BICYCLE THERAPEUTICS PLC (BCYC)
Thompson Travis Alvin — Chief Financial Officer
Shares
893
Price
$3.47
Total Value
$3.10K
Shares Held After
64,528
% of Holdings
1.4%
Intellia Therapeutics, Inc. (NTLA)
Dube Michael P — VP, Chief Accounting Officer
Shares
1,864
Price
$12.43
Total Value
$23.17K
Shares Held After
65,022
% of Holdings
2.8%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$8.57
Total Value
$857.24K
Shares Held After
314,000
% of Holdings
31.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
11,881
Price
$28.13
Total Value
$334.21K
Shares Held After
377,802
% of Holdings
3.0%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
5,147
Price
$116.58
Total Value
$600.06K
Shares Held After
3,946
% of Holdings
56.6%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
2,086
Price
$115.73
Total Value
$241.41K
Shares Held After
9,093
% of Holdings
18.7%
CORCEPT THERAPEUTICS INC (CORT)
Vieira Roberto Wandenkolk — President, Oncology
Shares
1,100
Price
$114.52
Total Value
$125.97K
Shares Held After
11,179
% of Holdings
9.0%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
8,744
Price
$116.55
Total Value
$1.02M
Shares Held After
9,938
% of Holdings
46.8%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
15,843
Price
$116.12
Total Value
$1.84M
Shares Held After
18,682
% of Holdings
45.9%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
4,744
Price
$116.54
Total Value
$552.87K
Shares Held After
5,683
% of Holdings
45.5%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting&Technology Officer
Shares
4,446
Price
$115.70
Total Value
$514.39K
Shares Held After
10,427
% of Holdings
29.9%
Immunovant, Inc. (IMVT)
Venker Eric — Director
Shares
3,506
Price
$34.11
Total Value
$119.59K
Shares Held After
257,075
% of Holdings
1.3%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
20,000
Price
$2.07
Total Value
$41.37K
Shares Held After
2,856,963
% of Holdings
0.7%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,307
Price
$1.33
Total Value
$11.05K
Shares Held After
916,839
% of Holdings
0.9%
PALISADE BIO, INC. (PALI)
Williams Donald Allen — Director
Shares
10,000
Price
$1.46
Total Value
$14.60K
Shares Held After
1,590,294
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$574.23
Total Value
$22.97K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$572.44
Total Value
$45.79K
Shares Held After
324,483
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$570.70
Total Value
$68.48K
Shares Held After
324,563
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$569.90
Total Value
$136.78K
Shares Held After
324,683
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$566.58
Total Value
$45.33K
Shares Held After
324,923
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$563.88
Total Value
$45.11K
Shares Held After
325,003
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$562.35
Total Value
$22.49K
Shares Held After
325,083
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$560.66
Total Value
$67.28K
Shares Held After
325,123
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$558.60
Total Value
$67.03K
Shares Held After
325,243
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$557.43
Total Value
$133.78K
Shares Held After
325,363
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$555.60
Total Value
$44.45K
Shares Held After
325,603
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$554.30
Total Value
$44.34K
Shares Held After
325,683
% of Holdings
0.0%
3003 transactions